Journal Article Summary
The article investigates the effectiveness and tolerability of oseltamivir prophylaxis compared to the seasonal influenza vaccine among Canadian health care workers during the 2007/2008 influenza season. This topic is significant because health care workers are at a higher risk of exposure to influenza, and understanding the best preventive measures can help reduce illness rates in this population. With limited data on acute respiratory illnesses in health care workers and the long-term use of antiviral medications, this study aims to fill that gap and provide insights into managing influenza risks in healthcare settings.
In this pilot study, 56 adult health care workers aged 18 to 69 were recruited and randomly assigned to receive either oseltamivir or the influenza vaccine. The results showed that the incidence of symptomatic, laboratory-confirmed influenza was similar between the two groups, with 17% of the vaccine group and 24% of the oseltamivir group affected. Participants reported working a significant number of scheduled days even when experiencing respiratory illness, with many feeling compelled to work despite being unwell. Adherence to oseltamivir was generally high, with most participants continuing the medication for an extended period, although some experienced side effects that led to discontinuation.
The study has limitations, including a small sample size and the fact that it was not designed to detect differences between the two groups or assess broader risk factors for illness. Additionally, the reliance on self-reported data for illness and adherence may have led to underreporting of respiratory infections. Readers should discuss their individual health circumstances with a healthcare professional, especially regarding vaccination and antiviral options, to make informed decisions about influenza prevention strategies.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Coleman Brenda L., Boggild Andrea K., Drews Steven J., Li Yan, Low Donald E., McGeer Allison J.. Respiratory illnesses in Canadian health care workers: a pilot study of influenza vaccine and oseltamivir prophylaxis during the 2007/2008 influenza season. Influenza and Other Respiratory Viruses 2011. DOI: 10.1111/j.1750-2659.2011.00245.x. PMID: 21668681. PMCID: PMC5780657.
Featured Pill Pals Product
Oseltamivir Phosphate 6 mg / ml Oral Suspension --- Generic For Tamiflu (60 ml Total) --- Ajanta Pharma
Oseltamivir Phosphate 6 mg / ml Oral Suspension — Generic For Tamiflu (60 ml Total) — Ajanta Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
